July 27, 2000Open Access

Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Our observations in patients with type 1 diabetes indicate that islet transplantation can result in insulin independence with excellent metabolic control when glucocorticoid-free immunosuppression is combined with the infusion of an adequate islet mass.

Leer artículo completoexternamente

Me gusta

Guardar

Ver artículo completo

Cite This Study

Shapiro et al. (Thu,) studied this question.

synapsesocial.com/papers/69d7dd7205ee2ba81dbee65a https://doi.org/https://doi.org/10.1056/nejm200007273430401

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.1998 · 425 citations
2Improved human islet isolation using a new enzyme blend, liberase1997 · 69 citations
3Effect of 15-deoxyspergualin on immediate function and long-term survival of transplanted islets in murine recipients of a marginal islet mass1994 · 24 citations
4PROLONGATION OF CANINE PANCREATIC ISLET ALLOGRAFT SURVIVAL WITH COMBINED RAPAMYCIN AND CYCLOSPORINE THERAPY AT LOW DOSES1993 · 65 citations
5Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.1975 · 958 citations

Me gusta

Guardar

Ver artículo completo